AI Assistant
Blog
Pricing
Log In
Sign Up
P-116 Infliximab and Adalimumab are Equally Effective in Prevention of Postoperative Endoscopic Recurrence in Crohnʼs Disease
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
